Navigation Links
ChemAxon Launches JChem for Excel

    BUDAPEST, July 16 /PRNewswire/ --
    - Introductory Webinar, July 21st, 11am EDT
    - End User Workshop at US User Group Meeting; September 15-16, San Diego,

ChemAxon, a software solutions provider for cheminformatics, today announced the launch of JChem for Excel. The add-in for Microsoft Excel(R) brings all of the capabilities and performance of the JChem and Marvin platform to Excel(R) users. The product will be introduced at a free webinar on July 21st and Workshop at the US UGM, September 15-16, San Diego, CA.

Marvin & JChem is a software suite used throughout life science research for working with chemistry and chemical structures. Marvin let's users draw and visualize structures and reactions, JChem is used for structure management and search, structure based prediction, library enumeration and library profiling.

Although only version 1, JChem for Excel already has advanced integration including; full support for structures (view, edit, search, order and manage), import/export a wide range of chemical file types or access remote databases, populating cells with structure based prediction results and R-group decomposition.

Speaking at the launch, Alex Drijver, CEO of ChemAxon commented "This is a game changing product, with Instant JChem desktop application already established and now JChem for Excel, we are well positioned to solve problems across the range; from end users on the desktop to system architects developing platforms."

JChem for Excel will be introduced and demonstrated at a free public webinar on July 21st at 11:00 AM EDT. To participate please register at this link:

JChem for Excel will also be demonstrated at ChemAxon's US User Group Meeting on September 15-16, San Diego, CA. To find out more see:

To download and freely evaluate JChem for Excel, please visit our website.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit

SOURCE ChemAxon Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook
2. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
3. ChemAxon Announces New CEO and Head of R&D
4. ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration
5. ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks
6. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
7. Novozymes Launches Enzyme to Reduce Acrylamide in Food
8. Enova Medical Launches Exos Corporation
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
11. ThirdBiotech Networking Group Launches
Post Your Comments:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):